Universal Vision Biotechnology Co., Ltd. (3218)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
146. 00
+1
+0.6897%
NT$
12.88B Market Cap
- P/E Ratio
30% Div Yield
200,409 Volume
- Eps
NT$ 145
Previous Close Want to track 3218 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Universal Vision Biotechnology Co., Ltd. (3218) Statistics
Valuation metrics
Market Cap 12.88B
Enterprise value 12.13B
Trailing P/E (ttm) 12.57
Forward P/E -
PEG ratio -0.86
Price/Sales (ttm) 2.89
Price/Book (mrq) 3.39
Enterprise Value/Revenue 2.91
Enterprise Value/EBITDA 7.39
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 290.12K
Average volume (90 days) 287.6K
Price summary
52-Week low 122
52-Week high 208
Beta -
50-Day moving average 137.53
200-Day moving average 136.38
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 7.75
Trailing annual dividend yield 0.0544%
5-Year annual dividend yield -
Payout ratio 0.66
Dividend Date 22 Apr 2026
Ex-Dividend Date 26 Mar 2026
Last split factor 1,060:1,000
Last split Date 25 Aug 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.23%
Operating margin 0.32%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.26%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 47.95
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 11.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 27.65
Total debt (mrq) -
Total Debt/Equity (mrq) 0.31
Current ratio (mrq) 1.91%
Book value per share (mrq) 43.51
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
